Montreal’s Reliant AI has launched out of stealth with $11 million in seed funding through a round co-led by Tola Capital and Inovia Capital. Founders Karl Moritz Hermann, Marc Bellemare, and Richard Schlegel are passionate about how generative AI can solve information challenges to reduce repetitive mental labor and accelerate decision making for enterprises.
The company says it is initially targeting the biopharma industry and that it will use the funding to hire engineering talent to expand its technology investment and footprints in North America. Reliant’s first product, Reliant Tabular, is an AI workbench that helps life science analysts find evidence for their decisions through automated systematic reviews, asset scans, and a customizable data platform.
Want to know more? Check out the source code here.